Cart
sales@molnova.com
Nexopamil
CAS No. 136033-49-3
Nexopamil( —— )
Catalog No. M34345 CAS No. 136033-49-3
Nexopamil (LU-49938) is a calcium channel antagonist and a 5-hydroxytryptamine 2A receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 182 | Get Quote |
|
| 5MG | 276 | Get Quote |
|
| 10MG | 418 | Get Quote |
|
| 25MG | 670 | Get Quote |
|
| 50MG | 908 | Get Quote |
|
| 100MG | 1251 | Get Quote |
|
| 500MG | 2493 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNexopamil
-
NoteResearch use only, not for human use.
-
Brief DescriptionNexopamil (LU-49938) is a calcium channel antagonist and a 5-hydroxytryptamine 2A receptor antagonist.
-
DescriptionNexopamil (LU-49938) is a calcium channel antagonist and a 5-hydroxytryptamine 2A receptor antagonist. Nexopamil inhibits 5-HT-induced contraction and proliferation of mesenchymal cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel | 5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136033-49-3
-
Formula Weight404.59
-
Molecular FormulaC24H40N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@@](CCCN(CCCCCC)C)(C(C)C)(C#N)C1=CC(OC)=C(OC)C(OC)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MMK 1
Potent and selective human formyl peptide receptor FPR2 agonist (EC50 values are 1, 2 and > 10 000 nM at mFRP2, hFPR2 and hFPR1 respectively). Induces migration of human monocytes and neutrophils via a chemotactic mechanism and enhances production of proinflammatory cytokines IL-1β and IL-6. Also activates the neutrophil superoxide-generating NADPH-oxidase.
-
Procyanidin A1
Procyanidin A1 has antiallergic effects, it inhibits degranulation downstream of protein kinase C activation or Ca2+; influx from an internal store in RBL-2H3 cells.
-
TROX-1
A potent, state-dependent blocker of Cav2 channels that preferentially inhibits potassium-triggered calcium influx through recombinant Cav2.2 under depolarized conditions with IC50 of 0.27 uM.
